Candriam SCA’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.84M Sell
2025
Q1
$6.82M Sell
2024
Q4
$12.3M Sell
2024
Q3
$12M Hold
2024
Q2
$10.5M Hold
2024
Q1
$12M Buy
2023
Q4
$11.2M Buy